ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0413

Pathogenic Characterization and Structural Insights of the Human IgG Autoantibodies Identified from Patients with Lupus Nephritis

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Author

  • Ka, Shuk-Man, National Defense Medical Center, Taipei City, Taiwan
Background

Autoantibodies that are strongly associated with lupus nephritis (LN) are a type of antinuclear antibody (ANA) that mainly target double-stranded DNA (dsDNA) and play a key role in disease diagnosis and monitoring. These anti-dsDNA antibodies can form immune complexes and deposit in the glomerular and tubular sites of the kidney, which may trigger inflammation activities and complement cascades and even penetrate into renal cells in LN patients.

Methods

In this study, we used a human hybridoma technology to identify two human IgG autoantibodies, LK01 and LK02, from a resident and a non-resident patient respectively.

Results

By analyzing their binding properties with human dsDNA and inflammatory responses in macrophages, LK02 was found to exhibit a higher binding avidity and stronger pro-inflammatory effects. Pathogenicity of lupus nephritis was evaluated in mouse models using immunofluorescence and electron microscopy, revealing substantial IgG deposition and complement activation in renal and skin tissues induced by both autoantibodies, with LK02 consistently showing superior results. The functional difference between two autoantibodies may be attributed to the different length and charge distribution of their HCDR loops. Molecular dynamics simulation was applied to analyze potential key residues involved in DNA binding on the predicted structure of LK02, and site-directed mutagenesis was done for amino-acid substitution, resulting in a modified autoantibody which outperformed the original one in both DNA binding and inflammatory induction.

Conclusion

Overall, this study has detailed the functional and structural profiles of two human LN-related autoantibodies and offered valuable insights that may inspire future research into autoantibody heterogeneity to enhance understanding of SLE pathogenesis.

Funding

  • Government Support – Non-U.S.